{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T18:58:46Z","timestamp":1794423526903,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02951-7","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:16:00Z","timestamp":1753708560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ruminococcus and prostate cancer: new treatment opportunities on the gut\u2013prostate axis"],"prefix":"10.1007","volume":"42","author":[{"given":"Yutong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"1","key":"2951_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12866-020-02021-0","volume":"20","author":"X Yuan","year":"2020","unstructured":"Yuan X, et al. Gut microbiota: effect of pubertal status. BMC Microbiol. 2020;20(1):334.","journal-title":"BMC Microbiol"},{"issue":"7285","key":"2951_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59\u201365.","journal-title":"Nature"},{"issue":"15","key":"2951_CR3","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1158\/0008-5472.CAN-20-4090","volume":"81","author":"M Matsushita","year":"2021","unstructured":"Matsushita M, et al. Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling. Cancer Res. 2021;81(15):4014\u201326.","journal-title":"Cancer Res"},{"issue":"12","key":"2951_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15698\/mic2022.12.787","volume":"9","author":"S Terrisse","year":"2022","unstructured":"Terrisse S, Zitvogel L, Kroemer G. Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy. Microb Cell. 2022;9(12):202\u20136.","journal-title":"Microb Cell"},{"issue":"6564","key":"2951_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.abf8403","volume":"374","author":"N Pernigoni","year":"2021","unstructured":"Pernigoni N, et al. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis. Science. 2021;374(6564):216\u201324.","journal-title":"Science"},{"key":"2951_CR6","doi-asserted-by":"publisher","first-page":"100928","DOI":"10.1016\/j.neo.2023.100928","volume":"43","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization. Neoplasia. 2023;43:100928.","journal-title":"Neoplasia"},{"key":"2951_CR7","doi-asserted-by":"publisher","first-page":"679712","DOI":"10.3389\/fonc.2021.679712","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Gut microbiota dysbiosis accelerates prostate cancer progression through increased LPCAT1 expression and enhanced DNA repair pathways. Front Oncol. 2021;11:679712.","journal-title":"Front Oncol"},{"issue":"5","key":"2951_CR8","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.21037\/tau-20-566","volume":"9","author":"Y Liu","year":"2020","unstructured":"Liu Y, Jiang H. Compositional differences of gut microbiome in matched hormone-sensitive and castration-resistant prostate cancer. Transl Androl Urol. 2020;9(5):1937\u201344.","journal-title":"Transl Androl Urol"},{"issue":"6564","key":"2951_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1126\/science.abl7070","volume":"374","author":"JA McCulloch","year":"2021","unstructured":"McCulloch JA, Trinchieri G. Gut bacteria enable prostate cancer growth. Science. 2021;374(6564):154\u20135.","journal-title":"Science"},{"issue":"4","key":"2951_CR10","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1210\/jc.2017-02114","volume":"103","author":"F Ottosson","year":"2018","unstructured":"Ottosson F, et al. Connection between BMI-related plasma metabolite profile and gut microbiota. J Clin Endocrinol Metab. 2018;103(4):1491\u2013501.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2951_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/aja.2012.145","volume":"15","author":"S Koochekpour","year":"2013","unstructured":"Koochekpour S. Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer. Asian J Androl. 2013;15(2):212\u20133.","journal-title":"Asian J Androl"},{"issue":"4","key":"2951_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/cancers14040967","volume":"14","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, et al. Prospect of prostate cancer treatment: armed CAR-T or combination therapy. Cancers (Basel). 2022;14(4):967.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2951_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","volume":"29","author":"CK Stein-Thoeringer","year":"2023","unstructured":"Stein-Thoeringer CK, et al. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nat Med. 2023;29(4):906\u201316.","journal-title":"Nat Med"},{"issue":"1","key":"2951_CR14","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, et al. Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12(1):4077.","journal-title":"Nat Commun"},{"issue":"1","key":"2951_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11912-024-01622-6","volume":"27","author":"L Gamrath","year":"2025","unstructured":"Gamrath L, et al. Role of the microbiome and diet for response to cancer checkpoint immunotherapy: a narrative review of clinical trials. Curr Oncol Rep. 2025;27(1):45\u201358.","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"2951_CR16","first-page":"492","volume":"62","author":"VJ Geberth","year":"1986","unstructured":"Geberth VJ. Mass, serial and sensational homicides: the investigative perspective. Bull N Y Acad Med. 1986;62(5):492\u20136.","journal-title":"Bull N Y Acad Med"},{"issue":"2","key":"2951_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1017\/S0007114515001750","volume":"114","author":"RK Le Leu","year":"2015","unstructured":"Le Leu RK, et al. Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: a randomised clinical trial. Br J Nutr. 2015;114(2):220\u201330.","journal-title":"Br J Nutr"},{"issue":"1","key":"2951_CR18","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1038\/s41467-024-45332-w","volume":"15","author":"G Lachance","year":"2024","unstructured":"Lachance G, et al. The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids. Nat Commun. 2024;15(1):3431.","journal-title":"Nat Commun"},{"issue":"6","key":"2951_CR19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1080\/07420528.2022.2044349","volume":"39","author":"H Morta\u015f","year":"2022","unstructured":"Morta\u015f H, et al. Changes in intestinal parameters and their association with dietary patterns in rotational shift workers. Chronobiol Int. 2022;39(6):872\u201385.","journal-title":"Chronobiol Int"},{"issue":"11","key":"2951_CR20","doi-asserted-by":"publisher","first-page":"001510","DOI":"10.1099\/mic.0.001510","volume":"170","author":"T Fujii","year":"2024","unstructured":"Fujii T, et al. Agarooligosaccharides as a novel concept in prebiotics: selective inhibition of Ruminococcus gnavus and Fusobacterium nucleatum while preserving Bifidobacteria, Lactobacillales in vitro, and inhibiting Lachnospiraceae in vivo. Microbiology (Reading). 2024;170(11):001510.","journal-title":"Microbiology (Reading)"},{"issue":"3","key":"2951_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/toxics11030281","volume":"11","author":"F Rashid","year":"2023","unstructured":"Rashid F, et al. Gut microbiome-host metabolome homeostasis upon exposure to PFOS and GenX in male mice. Toxics. 2023;11(3):281.","journal-title":"Toxics"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02951-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02951-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02951-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:46:01Z","timestamp":1757306761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02951-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["2951"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02951-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participant"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"387"}}